Patient Guide: A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 23 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06965413
Status: 🟢 Enrolling Now
Condition: Obesity, Overweight, Overweight With One Weight Related Comorbidity
Phase: PHASE2

Where You Can Participate

This study is available at 23 locations across the country.

Top locations include:
  • • Anniston, Alabama
  • • Spring Valley, California
  • • Orlando, Florida
  • • And 20 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity - Join Clinical Trial NCTNCT06965413

How to Join This Clinical Trial - NCTNCT06965413

Learn how to participate in this PHASE2 trial studying an investigational therapy for Obesity, Overweight, Overweight With One Weight Related Comorbidity. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Obesity, Overweight, Overweight With One Weight Related Comorbidity. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Obesity, Overweight, Overweight With One Weight Related Comorbidity
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06965413 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 23 locations. Find a study site near you:

Clinical Research Site

Anniston, Alabama 36207 - United States

Status: RECRUITING

Clinical Research Site

Spring Valley, California 91978 - United States

Status: RECRUITING

Clinical Research Site

Orlando, Florida 32806 - United States

Status: RECRUITING

Clinical Research Site

Union City, Georgia 30291 - United States

Status: RECRUITING

Clinical Research Site

Oak Lawn, Illinois 60453 - United States

Status: RECRUITING

Clinical Research Site

Rochester, New York 14609 - United States

Status: RECRUITING

Clinical Research Site

Salisbury, North Carolina 28144 - United States

Status: RECRUITING

Clinical Research Site

Statesville, North Carolina 28625 - United States

Status: RECRUITING

Clinical Research Site

Wilmington, North Carolina 28401 - United States

Status: RECRUITING

Clinical Research Site

Winston-Salem, North Carolina 27103 - United States

Status: RECRUITING

And 13 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Obesity, Overweight, Overweight With One Weight Related Comorbidity:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships